Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells.

作者: Renqin Duan , Erika Ginsburg , Barbara K. Vonderhaar

DOI: 10.1016/J.MCE.2007.10.004

关键词:

摘要: Abstract Human prolactin (hPRL) is a pleiotropic and versatile hormone that exercises more than 300 biological activities through binding to its cognate receptors. Recently, multiple studies have implicated hPRL in the development of human breast cancer. As target hPRL, both normal neoplastic cells also synthesize secrete which therefore establishes an autocrine/paracrine action loop mammary gland. In contrast extensive regulation expression pituitary gland, tissue cancer has not been extensively addressed. Extrapituitary PRL primarily regulated by distal promoter located 5.8 kb upstream promoter. result alternative usage, extrapituitary different signalling pathways hormones, cytokines or neuropeptides compared pituitary. Here, we present evidence shows estrogen directly induces gene T47D cells. We identified functional, non-canonical responsive element (ERE) AP1 site Gel shift chromatin immunoprecipitation assays demonstrated receptor (ER)α ERβ bind ERE. However, only ERα interacts with proteins Promoter–reporter demonstrate ERE sites are required for full induction activity estradiol. Our suggest interactions between estrogens, ERs, transcription factors may be critical oncogenesis contribute progression

参考文章(59)
T. L. M. Pasha, J. E. Tomaszewski, K. T. Montone, C. V. Clevenger, Wan-Ping Chang, Winnie Ngo, Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. American Journal of Pathology. ,vol. 146, pp. 695- 705 ,(1995)
Hiroo Imura, Norio Waseda, Yuzuru Kato, Masahiko Kurata, Prognostic value of estrogen and prolactin receptor analysis in human breast cancer. Japanese Journal of Cancer Research. ,vol. 76, pp. 517- 523 ,(1985) , 10.20772/CANCERSCI1985.76.6_517
Barbara K. Vonderhaar, Prolactin: the forgotten hormone of human breast cancer. Pharmacology & Therapeutics. ,vol. 79, pp. 169- 178 ,(1998) , 10.1016/S0163-7258(98)00017-5
Marta Llovera, Philippe Touraine, Paul A Kelly, Vincent Goffin, Involvement of prolactin in breast cancer: redefining the molecular targets. Experimental Gerontology. ,vol. 35, pp. 41- 51 ,(2000) , 10.1016/S0531-5565(99)00078-9
Nelson D. Horseman, Prolactin and mammary gland development. Journal of Mammary Gland Biology and Neoplasia. ,vol. 4, pp. 79- 88 ,(1999) , 10.1023/A:1018708704335
Monika Jakacka, Masafumi Ito, Jeffrey Weiss, Pei-Yu Chien, Barry D. Gehm, J. Larry Jameson, Estrogen Receptor Binding to DNA Is Not Required for Its Activity through the Nonclassical AP1 Pathway Journal of Biological Chemistry. ,vol. 276, pp. 13615- 13621 ,(2001) , 10.1074/JBC.M008384200
Marvin J. Meyers, Jun Sun, Kathryn E. Carlson, Benita S. Katzenellenbogen, John A. Katzenellenbogen, Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes. Journal of Medicinal Chemistry. ,vol. 42, pp. 2456- 2468 ,(1999) , 10.1021/JM990101B
Carol Reynolds, Kathleen T. Montone, Colleen M. Powell, John E. Tomaszewski, Charles V. Clevenger, Expression of prolactin and its receptor in human breast carcinoma. Endocrinology. ,vol. 138, pp. 5555- 5560 ,(1997) , 10.1210/ENDO.138.12.5605
Elizabeth Anderson, Janice E. Ferguson, Helen Morten, Steven M. Shalet, E.Lawrence Robinson, Antony Howell, Serum immunoreactive and bioactive lactogenic hormones in advanced breast cancer patients treated with bromocriptine and octreotide European Journal of Cancer. ,vol. 29, pp. 209- 217 ,(1993) , 10.1016/0959-8049(93)90178-I